These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 14506641)
1. Expression of alpha-methylacyl-CoA racemase (P504s) in various malignant neoplasms and normal tissues: astudy of 761 cases. Jiang Z; Fanger GR; Woda BA; Banner BF; Algate P; Dresser K; Xu J; Chu PG Hum Pathol; 2003 Aug; 34(8):792-6. PubMed ID: 14506641 [TBL] [Abstract][Full Text] [Related]
2. A dietary enzyme: alpha-methylacyl-CoA racemase/P504S is overexpressed in colon carcinoma. Jiang Z; Fanger GR; Banner BF; Woda BA; Algate P; Dresser K; Xu J; Reed SG; Rock KL; Chu PG Cancer Detect Prev; 2003; 27(6):422-6. PubMed ID: 14642549 [TBL] [Abstract][Full Text] [Related]
3. Expression and diagnostic utility of alpha-methylacyl-CoA-racemase (P504S) in foamy gland and pseudohyperplastic prostate cancer. Zhou M; Jiang Z; Epstein JI Am J Surg Pathol; 2003 Jun; 27(6):772-8. PubMed ID: 12766580 [TBL] [Abstract][Full Text] [Related]
4. Alpha-Methylacyl-CoA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions. Zhou M; Chinnaiyan AM; Kleer CG; Lucas PC; Rubin MA Am J Surg Pathol; 2002 Jul; 26(7):926-31. PubMed ID: 12131161 [TBL] [Abstract][Full Text] [Related]
5. Kinetic fluorescence reverse transcriptase-polymerase chain reaction for alpha-methylacyl CoA racemase distinguishes prostate cancer from benign lesions. Schostak M; Miller K; Krause H; Schrader M; Kempkensteffen C; Kollermann J Cancer Detect Prev; 2006; 30(5):449-54. PubMed ID: 17067752 [TBL] [Abstract][Full Text] [Related]
6. Utility of alpha-methylacyl coenzyme A racemase (p504s antibody) as a diagnostic immunohistochemical marker for cancer. Nassar A; Amin MB; Sexton DG; Cohen C Appl Immunohistochem Mol Morphol; 2005 Sep; 13(3):252-5. PubMed ID: 16082251 [TBL] [Abstract][Full Text] [Related]
7. Expression of alpha-methylacyl-CoA racemase in papillary renal cell carcinoma. Tretiakova MS; Sahoo S; Takahashi M; Turkyilmaz M; Vogelzang NJ; Lin F; Krausz T; Teh BT; Yang XJ Am J Surg Pathol; 2004 Jan; 28(1):69-76. PubMed ID: 14707866 [TBL] [Abstract][Full Text] [Related]
8. Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer. Luo J; Zha S; Gage WR; Dunn TA; Hicks JL; Bennett CJ; Ewing CM; Platz EA; Ferdinandusse S; Wanders RJ; Trent JM; Isaacs WB; De Marzo AM Cancer Res; 2002 Apr; 62(8):2220-6. PubMed ID: 11956072 [TBL] [Abstract][Full Text] [Related]
9. Alpha-methylacyl-CoA racemase (AMACR) protein is upregulated in early proliferative lesions of the breast irrespective of apocrine differentiation. Gatalica Z; Stafford P; Vranic S Hum Pathol; 2022 Nov; 129():40-46. PubMed ID: 35998819 [TBL] [Abstract][Full Text] [Related]
10. Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone. Leav I; McNeal JE; Ho SM; Jiang Z Hum Pathol; 2003 Mar; 34(3):228-33. PubMed ID: 12673556 [TBL] [Abstract][Full Text] [Related]
11. AMACR is highly expressed in gastric adenomas and intestinal-type carcinomas. Cho EY; Kim KM; Park CK; Kim JJ; Sohn TS; Kim DW APMIS; 2007 Jun; 115(6):713-8. PubMed ID: 17550379 [TBL] [Abstract][Full Text] [Related]
14. α-Methylacyl-CoA racemase: a useful immunohistochemical marker of breast carcinoma with apocrine differentiation. Nakamura H; Kukita Y; Kunimasa K; Kittaka N; Kusama H; Nakayama T; Tamaki Y; Sugiura R; Yasuda H; Hashimoto M; Yamamoto T; Imamura F; Nakatsuka SI Hum Pathol; 2021 Oct; 116():39-48. PubMed ID: 34314764 [TBL] [Abstract][Full Text] [Related]
15. Abundant expression of AMACR in many distinct tumour types. Went PT; Sauter G; Oberholzer M; Bubendorf L Pathology; 2006 Oct; 38(5):426-32. PubMed ID: 17008281 [TBL] [Abstract][Full Text] [Related]